Paper40451978
Familial adenomatous polyposis: non-surgical management of large bowel disease: endoscopic and chemoprevention strategies.
Daca-Álvarez M and 3 others. Fam Cancer, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Familial adenomatous polyposis: non-surgical management of large bowel disease: endoscopic and chemoprevention strategies. Papers, record 40451978. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40451978
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Familial adenomatous polyposis: non-surgical management of large bowel disease: endoscopic and chemoprevention strategies.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenomatous Polyposis Coli | Major topic |
| Chemoprevention | Major topic |
| Colonoscopy | Major topic |
| Colorectal Neoplasms | Major topic |
| Humans | |
| Colectomy |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25810493 | Colorectal cancer prevention and fishful thinking. | J Natl Cancer Inst | 2015 | https://conductscience.org/library/papers/25810493 | PubMed |
| 2 | 7049351 | A randomized trial of ascorbic acid in polyposis coli. | Cancer | 1982 | https://conductscience.org/library/papers/7049351 | PubMed |
| 3 | 23949425 | Risk of neoplastic change in ileal pouches in familial adenomatous polyposis. | J Gastrointest Surg | 2013 | https://conductscience.org/library/papers/23949425 | PubMed |
| 4 | 29423501 | Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial. | JAMA Oncol | 2018 | https://conductscience.org/library/papers/29423501 | PubMed |
| 5 | 35570229 | Long-term chemoprevention in patients with adenomatous polyposis coli: an observational study. | Fam Cancer | 2022 | https://conductscience.org/library/papers/35570229 | PubMed |
| 6 | 35636921 | Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis. | Gut | 2023 | https://conductscience.org/library/papers/35636921 | PubMed |
| 7 | 23885143 | Phytoestrogens/insoluble fibers and colonic estrogen receptor β: randomized, double-blind, placebo-controlled study. | World J Gastroenterol | 2013 | https://conductscience.org/library/papers/23885143 | PubMed |
| 8 | 10874062 | The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. | N Engl J Med | 2000 | https://conductscience.org/library/papers/10874062 | PubMed |
| 9 | 12972960 | Risk of rectal cancer in patients after colectomy and ileorectal anastomosis for familial adenomatous polyposis: a function of available surgical options. | Dis Colon Rectum | 2003 | https://conductscience.org/library/papers/12972960 | PubMed |
| 10 | 7634976 | Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months. | Dis Colon Rectum | 1995 | https://conductscience.org/library/papers/7634976 | PubMed |
| 11 | 1650315 | Sulindac causes regression of rectal polyps in familial adenomatous polyposis. | Gastroenterology | 1991 | https://conductscience.org/library/papers/1650315 | PubMed |
| 12 | 24764585 | A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis. | Cancer Prev Res (Phila) | 2014 | https://conductscience.org/library/papers/24764585 | PubMed |
| 13 | 21543343 | A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. | Cancer Prev Res (Phila) | 2011 | https://conductscience.org/library/papers/21543343 | PubMed |
| 14 | 34610992 | Celecoxib Colorectal Bioavailability and Chemopreventive Response in Patients with Familial Adenomatous Polyposis. | Cancer Prev Res (Phila) | 2022 | https://conductscience.org/library/papers/34610992 | PubMed |
| 15 | 8385741 | Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8385741 | PubMed |
| 16 | 33376109 | Sirolimus for the treatment of polyposis of the rectal remnant and ileal pouch in four patients with familial adenomatous polyposis: a pilot study. | BMJ Open Gastroenterol | 2020 | https://conductscience.org/library/papers/33376109 | PubMed |
| 17 | 27002448 | Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial. | JAMA | 2016 | https://conductscience.org/library/papers/27002448 | PubMed |
| 18 | 11932472 | Primary chemoprevention of familial adenomatous polyposis with sulindac. | N Engl J Med | 2002 | https://conductscience.org/library/papers/11932472 | PubMed |
| 19 | 8859177 | Effect of indomethacin suppositories on rectal polyposis in patients with familial adenomatous polyposis. | Cancer | 1996 | https://conductscience.org/library/papers/8859177 | PubMed |
| 20 | 35812028 | Role of endoscopy in patients with familial adenomatous polyposis. | Frontline Gastroenterol | 2022 | https://conductscience.org/library/papers/35812028 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42315912 | MCM2 germline variants predispose to familial papillary thyroid carcinoma due to genomic instability caused by MCM complex disruption. | Oncogene | 2026 | https://conductscience.org/library/papers/42315912 | PubMed |
| 42239884 | Advances in chemoprevention of familial adenomatous polyposis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42239884 | PubMed |
| 41228253 | Advances in Hereditary Colorectal Cancer: How Precision Medicine Is Changing the Game. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41228253 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| APC | 324 | PubTator's text mining | https://conductscience.org/library/genes/324 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40451978
GET https://conductscience.org/api/papers/v1/40451978/references?page=2